Pharmacyclics, Inc. (PCYC) Blows Up Q2 Views, Posts Surprise Profit

Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of $0.82, $1.00 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $2.64 million.

For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• BMO Capital on FedEx (FDX): 'Guidance Appears Consistent With Our Forecasts'
• KB Home (KBH) PT Raised to $56 at Truist Securities